BioSpace News Archive

Abbott will announce its third-quarter 2019 financial results on Wednesday, Oct. 16, 2019, before the market opens.

Phase 2 clinical trial initiated and enrollment progressing across 24 sites

This market report provides a detailed analysis of the market by type (biologics and small molecules) and geography (Asia, Europe, North America, and ROW).

Olympus Commits to Open Dialogue, Unconscious Bias Education, Collaboration with Other Corporate Leaders and the Creation of Strategic Diversity and Inclusion Paths

Update Further Optimizes All-in-One e-Clinical Solution to Meet Evolving Demands of Clinical Research

Huntington National Bank and Quantum Health presentation highlights how early and persistent engagement drives higher employee satisfaction and lowers plan costs

Earlier this year, EVP/CEO Thomas E. Menighan, BPharm, MBA, ScD (Hon), announced his retirement, effective at midyear 2020.

Polaris RZR®, the world’s No.1-selling sport performance side-by-side, and Nitro Circus, the worldwide leader in action sports entertainment, have partnered to deliver the ultimate adrenaline rush to the Camp RZR 2019 event.

Ping An Insurance Company of China, Ltd. is pleased to announce Ping An Global Voyager Fund is leading an investment of US$15 Million in Riverain Technologies, a leading provider of clinical artificial intelligence software used to efficiently detect lung disease at its earliest stages.

Biovica and the SWOG Cancer Research Network have entered into an agreement to study the clinical benefit of DiviTum® using patient blood samples from SWOG 0226, a clinical trial that showed that women with metastatic hormone receptor-positive breast cancer live longer when they receive a combination of two anti-estrogen drugs.